Log in to search using one of your social media accounts:


99m Tc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis

ConclusionsARR of SLNB-negative patients with99mTc-rituximab is low. Abnormal axillary ultrasound with negative FNA, not receiving radiotherapy, and age  ≤ 40 years were prognostic factors for higher ARRs.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research

Related Links:

More News: Breast Cancer | Breast Needle Aspiration | Cancer | Cancer & Oncology | Rituxan | Study | Ultrasound